Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 9.99742224 |
2 | keratan sulfate catabolic process (GO:0042340) | 8.98522876 |
3 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 8.71258155 |
4 | lung epithelium development (GO:0060428) | 8.70498377 |
5 | embryonic camera-type eye development (GO:0031076) | 7.91950867 |
6 | limb bud formation (GO:0060174) | 7.81146275 |
7 | protein localization to cell surface (GO:0034394) | 7.41269347 |
8 | organ growth (GO:0035265) | 7.37014908 |
9 | muscle cell fate commitment (GO:0042693) | 7.34216059 |
10 | camera-type eye morphogenesis (GO:0048593) | 6.87766305 |
11 | genitalia morphogenesis (GO:0035112) | 6.85452985 |
12 | cornea development in camera-type eye (GO:0061303) | 6.82301642 |
13 | white fat cell differentiation (GO:0050872) | 6.75047309 |
14 | bicarbonate transport (GO:0015701) | 6.48712221 |
15 | mesonephros development (GO:0001823) | 6.24573188 |
16 | branch elongation of an epithelium (GO:0060602) | 6.10916052 |
17 | myoblast migration (GO:0051451) | 6.08469079 |
18 | extracellular matrix assembly (GO:0085029) | 5.99343947 |
19 | induction of positive chemotaxis (GO:0050930) | 5.85219383 |
20 | kidney morphogenesis (GO:0060993) | 5.84293969 |
21 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 5.52175188 |
22 | lung secretory cell differentiation (GO:0061140) | 5.50543111 |
23 | keratinocyte proliferation (GO:0043616) | 5.25277069 |
24 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 5.23470475 |
25 | regulation of skeletal muscle contraction (GO:0014819) | 4.87161320 |
26 | organ induction (GO:0001759) | 4.82343545 |
27 | embryonic digestive tract morphogenesis (GO:0048557) | 4.81322919 |
28 | cellular sodium ion homeostasis (GO:0006883) | 4.79118058 |
29 | keratan sulfate biosynthetic process (GO:0018146) | 4.74029040 |
30 | axis elongation (GO:0003401) | 4.68077742 |
31 | muscle filament sliding (GO:0030049) | 4.62315709 |
32 | actin-myosin filament sliding (GO:0033275) | 4.62315709 |
33 | morphogenesis of an epithelial fold (GO:0060571) | 4.60967422 |
34 | protein heterotrimerization (GO:0070208) | 4.55882304 |
35 | negative regulation of cell cycle arrest (GO:0071157) | 4.48716646 |
36 | epithelial cell-cell adhesion (GO:0090136) | 4.47274770 |
37 | organ formation (GO:0048645) | 4.37091331 |
38 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.33096284 |
39 | regulation of keratinocyte proliferation (GO:0010837) | 4.17251315 |
40 | smooth muscle cell differentiation (GO:0051145) | 4.08296243 |
41 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 4.07131622 |
42 | establishment of mitotic spindle orientation (GO:0000132) | 4.00826404 |
43 | regulation of bile acid biosynthetic process (GO:0070857) | 3.95153691 |
44 | plasma membrane repair (GO:0001778) | 3.94356776 |
45 | thyroid gland development (GO:0030878) | 3.93311415 |
46 | extracellular fibril organization (GO:0043206) | 3.92343570 |
47 | peptidyl-proline hydroxylation (GO:0019511) | 3.91551437 |
48 | keratan sulfate metabolic process (GO:0042339) | 3.90436155 |
49 | collagen fibril organization (GO:0030199) | 3.90106298 |
50 | cell migration involved in heart development (GO:0060973) | 3.88347207 |
51 | actin-mediated cell contraction (GO:0070252) | 3.85931587 |
52 | regulation of digestive system process (GO:0044058) | 3.83967947 |
53 | venous blood vessel morphogenesis (GO:0048845) | 3.82814284 |
54 | regulation of cholesterol homeostasis (GO:2000188) | 3.80862074 |
55 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.77172607 |
56 | cardiac muscle cell proliferation (GO:0060038) | 3.70056059 |
57 | skeletal muscle contraction (GO:0003009) | 3.69980338 |
58 | establishment of spindle orientation (GO:0051294) | 3.68695523 |
59 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.67411301 |
60 | mesenchymal cell differentiation (GO:0048762) | 3.65351020 |
61 | prostate gland epithelium morphogenesis (GO:0060740) | 3.64063181 |
62 | complement activation, alternative pathway (GO:0006957) | 3.63421106 |
63 | glomerular filtration (GO:0003094) | 3.61925216 |
64 | ERK1 and ERK2 cascade (GO:0070371) | 3.61854099 |
65 | skeletal muscle fiber development (GO:0048741) | 3.61708643 |
66 | positive regulation of p38MAPK cascade (GO:1900745) | 3.57308441 |
67 | striated muscle cell proliferation (GO:0014855) | 3.50948710 |
68 | muscle cell migration (GO:0014812) | 3.48779793 |
69 | regulation of p38MAPK cascade (GO:1900744) | 3.46029472 |
70 | tissue regeneration (GO:0042246) | 3.45124829 |
71 | fibril organization (GO:0097435) | 3.39675122 |
72 | cellular response to cadmium ion (GO:0071276) | 3.38870325 |
73 | vitamin A metabolic process (GO:0006776) | 3.38662250 |
74 | positive chemotaxis (GO:0050918) | 3.34876353 |
75 | neuronal action potential propagation (GO:0019227) | 3.34134474 |
76 | negative regulation of heart growth (GO:0061117) | 3.33634168 |
77 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.33634168 |
78 | establishment of mitotic spindle localization (GO:0040001) | 3.32854185 |
79 | response to leptin (GO:0044321) | 3.31965469 |
80 | protein hydroxylation (GO:0018126) | 3.30189851 |
81 | renal filtration (GO:0097205) | 3.29676499 |
82 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.29648458 |
83 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.28902417 |
84 | behavioral response to pain (GO:0048266) | 3.26568294 |
85 | endothelial cell morphogenesis (GO:0001886) | 3.21156848 |
86 | establishment of nucleus localization (GO:0040023) | 3.15353541 |
87 | * skeletal muscle adaptation (GO:0043501) | 3.13102446 |
88 | positive regulation of positive chemotaxis (GO:0050927) | 3.12106417 |
89 | 4-hydroxyproline metabolic process (GO:0019471) | 3.11420595 |
90 | sulfur compound catabolic process (GO:0044273) | 3.11088331 |
91 | myotube cell development (GO:0014904) | 3.10764269 |
92 | regulation of plasminogen activation (GO:0010755) | 3.10697514 |
93 | hair follicle morphogenesis (GO:0031069) | 3.08154181 |
94 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.08122985 |
95 | actin filament-based movement (GO:0030048) | 3.06427898 |
96 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.05513603 |
97 | bone trabecula formation (GO:0060346) | 2.98753159 |
98 | regulation of positive chemotaxis (GO:0050926) | 2.96610337 |
99 | collagen metabolic process (GO:0032963) | 2.95814998 |
100 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.94912401 |
101 | barbed-end actin filament capping (GO:0051016) | 2.94627546 |
102 | skin morphogenesis (GO:0043589) | 2.92190490 |
103 | prostaglandin biosynthetic process (GO:0001516) | 2.91928215 |
104 | prostanoid biosynthetic process (GO:0046457) | 2.91928215 |
105 | fluid transport (GO:0042044) | 2.91132466 |
106 | regulation of activin receptor signaling pathway (GO:0032925) | 2.91127741 |
107 | creatine metabolic process (GO:0006600) | 2.90277833 |
108 | growth hormone secretion (GO:0030252) | 2.90022097 |
109 | synaptic vesicle maturation (GO:0016188) | 2.88232390 |
110 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.86877226 |
111 | positive regulation of Notch signaling pathway (GO:0045747) | 2.86801125 |
112 | regulation of circadian sleep/wake cycle (GO:0042749) | 2.86332950 |
113 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 2.86332950 |
114 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.85921426 |
115 | locomotory exploration behavior (GO:0035641) | 2.84972781 |
116 | sodium ion export (GO:0071436) | 2.84411110 |
117 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.84399410 |
118 | regulation of complement activation (GO:0030449) | 2.81223220 |
119 | regulation of cell communication by electrical coupling (GO:0010649) | 2.80940344 |
120 | lymph vessel development (GO:0001945) | 2.80457996 |
121 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.80120019 |
122 | positive regulation of neutrophil migration (GO:1902624) | 2.80120019 |
123 | regulation of fibroblast migration (GO:0010762) | 2.79812805 |
124 | eye morphogenesis (GO:0048592) | 2.79788069 |
125 | collagen catabolic process (GO:0030574) | 2.79484867 |
126 | striated muscle contraction (GO:0006941) | 2.79204450 |
127 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.78523761 |
128 | glycogen catabolic process (GO:0005980) | 2.77880582 |
129 | muscle cell proliferation (GO:0033002) | 2.77682804 |
130 | dopaminergic neuron differentiation (GO:0071542) | 2.77658759 |
131 | potassium ion import (GO:0010107) | 2.77234163 |
132 | developmental induction (GO:0031128) | 2.76942995 |
133 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.76638935 |
134 | myoblast fusion (GO:0007520) | 2.76331501 |
135 | cellular response to nitric oxide (GO:0071732) | 2.75858905 |
136 | sodium ion homeostasis (GO:0055078) | 2.74152467 |
137 | response to prostaglandin E (GO:0034695) | 2.73571779 |
138 | regulation of organ formation (GO:0003156) | 2.73558735 |
139 | cyclooxygenase pathway (GO:0019371) | 2.72505215 |
140 | cellular potassium ion homeostasis (GO:0030007) | 2.72008308 |
141 | multicellular organismal metabolic process (GO:0044236) | 2.70646748 |
142 | phosphate ion transmembrane transport (GO:0035435) | 2.67821297 |
143 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.66760507 |
144 | blood circulation (GO:0008015) | 2.66147209 |
145 | negative regulation of muscle hypertrophy (GO:0014741) | 2.65501978 |
146 | cellular response to electrical stimulus (GO:0071257) | 2.65335448 |
147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.65155557 |
148 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.65066642 |
149 | transepithelial transport (GO:0070633) | 2.63453132 |
150 | polyol transport (GO:0015791) | 2.63069380 |
151 | temperature homeostasis (GO:0001659) | 2.62821779 |
152 | myofibril assembly (GO:0030239) | 2.62482734 |
153 | glutamate secretion (GO:0014047) | 2.62347336 |
154 | multicellular organismal catabolic process (GO:0044243) | 2.61295539 |
155 | metanephric nephron tubule development (GO:0072234) | 2.60690560 |
156 | metanephric tubule development (GO:0072170) | 2.60690560 |
157 | neuromuscular junction development (GO:0007528) | 2.60406917 |
158 | pancreas development (GO:0031016) | 2.57915107 |
159 | positive regulation of small GTPase mediated signal transduction (GO:0051057) | 2.57651839 |
160 | glucan catabolic process (GO:0009251) | 2.56583994 |
161 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.55531756 |
162 | cytolysis (GO:0019835) | 2.52403500 |
163 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.51713906 |
164 | regulation of protein activation cascade (GO:2000257) | 2.50597697 |
165 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.50019992 |
166 | cellular polysaccharide biosynthetic process (GO:0033692) | 2.48037336 |
167 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.47661445 |
168 | polysaccharide biosynthetic process (GO:0000271) | 2.47645745 |
169 | L-amino acid import (GO:0043092) | 2.46403016 |
170 | neuromuscular synaptic transmission (GO:0007274) | 2.45235629 |
171 | blood vessel maturation (GO:0001955) | 2.43484458 |
172 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.41449159 |
173 | detection of molecule of bacterial origin (GO:0032490) | 2.41303280 |
174 | sarcomere organization (GO:0045214) | 2.40497318 |
175 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.40105017 |
176 | negative regulation of complement activation (GO:0045916) | 2.39899688 |
177 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.39843796 |
178 | glycosaminoglycan catabolic process (GO:0006027) | 2.39650092 |
179 | carnitine shuttle (GO:0006853) | 2.37146885 |
180 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.37027961 |
181 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.37027961 |
182 | polysaccharide catabolic process (GO:0000272) | 2.36184752 |
183 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.36095932 |
184 | muscle contraction (GO:0006936) | 2.35343561 |
185 | oxygen transport (GO:0015671) | 2.35178347 |
186 | ovulation cycle (GO:0042698) | 2.33821409 |
187 | glycosaminoglycan biosynthetic process (GO:0006024) | 2.32755734 |
188 | glomerular basement membrane development (GO:0032836) | 14.5655566 |
189 | mesenchymal-epithelial cell signaling (GO:0060638) | 12.0117442 |
190 | otic vesicle formation (GO:0030916) | 11.6475845 |
191 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 10.3948746 |
192 | radial glial cell differentiation (GO:0060019) | 10.2416648 |
193 | lateral sprouting from an epithelium (GO:0060601) | 10.1652149 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.68976433 |
2 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.79417281 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.74331060 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.44143577 |
5 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37572627 |
6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37572627 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32528114 |
8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27005494 |
9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.25142475 |
10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.23862134 |
11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.19500630 |
12 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18705295 |
13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.16385761 |
14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13763791 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11711999 |
16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.07760748 |
17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.04006445 |
18 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 2.01536817 |
19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.99713224 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98621694 |
21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.98275351 |
22 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.90303415 |
23 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.89952841 |
24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89844024 |
25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86149204 |
26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.83929277 |
27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83767566 |
28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.80908002 |
29 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.79347566 |
30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.77514015 |
31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73768190 |
32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.71901445 |
33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71324922 |
34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71250435 |
35 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67946484 |
36 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55840766 |
37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53677310 |
38 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.47621075 |
39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.46191833 |
40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43978399 |
41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40094429 |
42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.39290802 |
43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.39264672 |
44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39106855 |
45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37990999 |
46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35287869 |
47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32749512 |
48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31505886 |
49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31493600 |
50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31146001 |
51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29974066 |
52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29803173 |
53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29318193 |
54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28916071 |
55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28368267 |
56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25636113 |
57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24976554 |
58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23197847 |
59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23171277 |
60 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23086238 |
61 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22292867 |
62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20155183 |
63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19083720 |
64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17888389 |
65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16516234 |
66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15882654 |
67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15689320 |
68 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15689320 |
69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.15283501 |
70 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12533393 |
71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09892602 |
72 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08730234 |
73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06613098 |
74 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06613098 |
75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06452397 |
76 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06210345 |
77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06028505 |
78 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05658146 |
79 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05193103 |
80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04951932 |
81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03954036 |
82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03915261 |
83 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02815101 |
84 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02813227 |
85 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02710589 |
86 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.02533230 |
87 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.02467121 |
88 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02436285 |
89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01621811 |
90 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01431895 |
91 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01124730 |
92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00930030 |
93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00842844 |
94 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00310021 |
95 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98854170 |
96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98360343 |
97 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.98345818 |
98 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97419878 |
99 | AR_19668381_ChIP-Seq_PC3_Human | 0.97316922 |
100 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.96936099 |
101 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96198377 |
102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95535743 |
103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94736185 |
104 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.94699736 |
105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94259425 |
106 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94115081 |
107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93792373 |
108 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93153684 |
109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.92838919 |
110 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92576920 |
111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91661081 |
112 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90734065 |
113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.90031141 |
114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89915963 |
115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89682382 |
116 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89056052 |
117 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88798142 |
118 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.87278844 |
119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86911419 |
120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86722605 |
121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86563227 |
122 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86353184 |
123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85526396 |
124 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.85306936 |
125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84526449 |
126 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.84507900 |
127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84033412 |
128 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83848458 |
129 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.82953869 |
130 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82036871 |
131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81617930 |
132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80775885 |
133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80669860 |
134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80645944 |
135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80389419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005503_abnormal_tendon_morphology | 7.50112181 |
2 | MP0002102_abnormal_ear_morphology | 6.92423458 |
3 | MP0005275_abnormal_skin_tensile | 6.70406216 |
4 | MP0008438_abnormal_cutaneous_collagen | 5.80001609 |
5 | MP0000751_myopathy | 4.66399517 |
6 | MP0002132_abnormal_respiratory_system | 4.03259451 |
7 | MP0001661_extended_life_span | 4.02603769 |
8 | MP0005248_abnormal_Harderian_gland | 3.93214001 |
9 | MP0004145_abnormal_muscle_electrophysio | 3.83347575 |
10 | MP0002108_abnormal_muscle_morphology | 3.35434892 |
11 | MP0000749_muscle_degeneration | 3.13825503 |
12 | MP0003646_muscle_fatigue | 3.04730438 |
13 | MP0000747_muscle_weakness | 2.95804147 |
14 | MP0002277_abnormal_respiratory_mucosa | 2.50188631 |
15 | MP0004859_abnormal_synaptic_plasticity | 2.47102284 |
16 | MP0004742_abnormal_vestibular_system | 2.42763054 |
17 | MP0005369_muscle_phenotype | 2.39566368 |
18 | MP0001958_emphysema | 2.25048055 |
19 | MP0002106_abnormal_muscle_physiology | 2.23756546 |
20 | MP0003705_abnormal_hypodermis_morpholog | 2.08371463 |
21 | MP0010030_abnormal_orbit_morphology | 2.06843266 |
22 | MP0002909_abnormal_adrenal_gland | 2.04694237 |
23 | MP0000750_abnormal_muscle_regeneration | 2.01495885 |
24 | MP0003878_abnormal_ear_physiology | 10.0125227 |
25 | MP0005377_hearing/vestibular/ear_phenot | 10.0125227 |
26 | MP0000759_abnormal_skeletal_muscle | 1.96472020 |
27 | MP0004087_abnormal_muscle_fiber | 1.93792746 |
28 | MP0005508_abnormal_skeleton_morphology | 1.87670162 |
29 | MP0004036_abnormal_muscle_relaxation | 1.82477817 |
30 | MP0004130_abnormal_muscle_cell | 1.79964892 |
31 | MP0002837_dystrophic_cardiac_calcinosis | 1.71007648 |
32 | MP0006072_abnormal_retinal_apoptosis | 1.69513029 |
33 | MP0004270_analgesia | 1.68765323 |
34 | MP0002269_muscular_atrophy | 1.63614720 |
35 | MP0002060_abnormal_skin_morphology | 1.63521916 |
36 | MP0001756_abnormal_urination | 1.60079400 |
37 | MP0003279_aneurysm | 1.51821790 |
38 | MP0009780_abnormal_chondrocyte_physiolo | 1.48496283 |
39 | MP0004272_abnormal_basement_membrane | 1.45237160 |
40 | MP0005620_abnormal_muscle_contractility | 1.43516595 |
41 | MP0004858_abnormal_nervous_system | 1.43170714 |
42 | MP0002090_abnormal_vision | 1.41202433 |
43 | MP0000566_synostosis | 1.39536135 |
44 | MP0003075_altered_response_to | 1.37977437 |
45 | MP0001502_abnormal_circadian_rhythm | 1.36881302 |
46 | MP0005193_abnormal_anterior_eye | 1.32334254 |
47 | MP0000013_abnormal_adipose_tissue | 1.30352164 |
48 | MP0004233_abnormal_muscle_weight | 1.28852685 |
49 | MP0000733_abnormal_muscle_development | 1.26015455 |
50 | MP0006054_spinal_hemorrhage | 1.24192551 |
51 | MP0003011_delayed_dark_adaptation | 1.22201185 |
52 | MP0002009_preneoplasia | 1.22198095 |
53 | MP0005670_abnormal_white_adipose | 1.16580775 |
54 | MP0003635_abnormal_synaptic_transmissio | 1.16011254 |
55 | MP0004185_abnormal_adipocyte_glucose | 1.11053601 |
56 | MP0008569_lethality_at_weaning | 1.09540451 |
57 | MP0005330_cardiomyopathy | 1.09311631 |
58 | MP0003938_abnormal_ear_development | 1.06448619 |
59 | MP0002295_abnormal_pulmonary_circulatio | 1.06311161 |
60 | MP0009250_abnormal_appendicular_skeleto | 1.06256405 |
61 | MP0004043_abnormal_pH_regulation | 1.05638588 |
62 | MP0003879_abnormal_hair_cell | 1.05038755 |
63 | MP0000026_abnormal_inner_ear | 1.04754039 |
64 | MP0001299_abnormal_eye_distance/ | 1.04235164 |
65 | MP0002796_impaired_skin_barrier | 1.03592786 |
66 | MP0002933_joint_inflammation | 0.97570358 |
67 | MP0000613_abnormal_salivary_gland | 0.92798686 |
68 | MP0005390_skeleton_phenotype | 0.92665128 |
69 | MP0003045_fibrosis | 0.89855659 |
70 | MP0010368_abnormal_lymphatic_system | 0.88463716 |
71 | MP0003303_peritoneal_inflammation | 0.85817558 |
72 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82397626 |
73 | MP0004484_altered_response_of | 0.80960109 |
74 | MP0009384_cardiac_valve_regurgitation | 0.80913105 |
75 | MP0004215_abnormal_myocardial_fiber | 0.79981640 |
76 | MP0000163_abnormal_cartilage_morphology | 0.79717079 |
77 | MP0002089_abnormal_postnatal_growth/wei | 0.78230250 |
78 | MP0004084_abnormal_cardiac_muscle | 0.77551147 |
79 | MP0001501_abnormal_sleep_pattern | 0.77099578 |
80 | MP0009046_muscle_twitch | 0.76846460 |
81 | MP0002697_abnormal_eye_size | 0.76599375 |
82 | MP0005197_abnormal_uvea_morphology | 0.76019918 |
83 | MP0005171_absent_coat_pigmentation | 0.75143984 |
84 | MP0003690_abnormal_glial_cell | 0.75069539 |
85 | MP0001963_abnormal_hearing_physiology | 0.74607581 |
86 | MP0002896_abnormal_bone_mineralization | 0.74487521 |
87 | MP0002332_abnormal_exercise_endurance | 0.73186776 |
88 | MP0003329_amyloid_beta_deposits | 0.72678931 |
89 | MP0000762_abnormal_tongue_morphology | 0.72420593 |
90 | MP0005332_abnormal_amino_acid | 0.72199832 |
91 | MP0002876_abnormal_thyroid_physiology | 0.72062229 |
92 | MP0005076_abnormal_cell_differentiation | 0.71933827 |
93 | MP0005666_abnormal_adipose_tissue | 0.71141581 |
94 | MP0009643_abnormal_urine_homeostasis | 0.71058962 |
95 | MP0004134_abnormal_chest_morphology | 0.70846359 |
96 | MP0009745_abnormal_behavioral_response | 0.70817242 |
97 | MP0002006_tumorigenesis | 0.70662255 |
98 | MP0002064_seizures | 0.70526670 |
99 | MP0003385_abnormal_body_wall | 0.70170897 |
100 | MP0000579_abnormal_nail_morphology | 0.69853323 |
101 | MP0010771_integument_phenotype | 0.69738425 |
102 | MP0003115_abnormal_respiratory_system | 0.69170768 |
103 | MP0002115_abnormal_skeleton_extremities | 0.69100430 |
104 | MP0000230_abnormal_systemic_arterial | 0.68892446 |
105 | MP0003941_abnormal_skin_development | 0.68334420 |
106 | MP0002063_abnormal_learning/memory/cond | 0.68323138 |
107 | MP0002166_altered_tumor_susceptibility | 0.68065860 |
108 | MP0002971_abnormal_brown_adipose | 0.67516435 |
109 | MP0005375_adipose_tissue_phenotype | 0.66920001 |
110 | MP0008961_abnormal_basal_metabolism | 0.66612120 |
111 | MP0000343_altered_response_to | 0.65742851 |
112 | MP0004510_myositis | 0.65209275 |
113 | MP0005165_increased_susceptibility_to | 0.64330345 |
114 | MP0002972_abnormal_cardiac_muscle | 0.63838054 |
115 | MP0003283_abnormal_digestive_organ | 0.61946252 |
116 | MP0005623_abnormal_meninges_morphology | 0.61578216 |
117 | MP0010630_abnormal_cardiac_muscle | 0.61508131 |
118 | MP0000767_abnormal_smooth_muscle | 0.61482782 |
119 | MP0002734_abnormal_mechanical_nocicepti | 0.61206066 |
120 | MP0003633_abnormal_nervous_system | 0.60852644 |
121 | MP0001243_abnormal_dermal_layer | 0.57972536 |
122 | MP0003119_abnormal_digestive_system | 0.57541897 |
123 | MP0002272_abnormal_nervous_system | 0.56605733 |
124 | MP0002136_abnormal_kidney_physiology | 0.56559001 |
125 | MP0005253_abnormal_eye_physiology | 0.56467915 |
126 | MP0005388_respiratory_system_phenotype | 0.56341253 |
127 | MP0002133_abnormal_respiratory_system | 0.56341253 |
128 | MP0000003_abnormal_adipose_tissue | 0.56123139 |
129 | MP0005365_abnormal_bile_salt | 0.54521659 |
130 | MP0003091_abnormal_cell_migration | 0.53621415 |
131 | MP0001879_abnormal_lymphatic_vessel | 0.53557927 |
132 | MP0002932_abnormal_joint_morphology | 0.51338307 |
133 | MP0001177_atelectasis | 0.51333511 |
134 | MP0003937_abnormal_limbs/digits/tail_de | 0.50542129 |
135 | MP0000372_irregular_coat_pigmentation | 0.50428264 |
136 | MP0004085_abnormal_heartbeat | 0.50178519 |
137 | MP0001486_abnormal_startle_reflex | 0.49722169 |
138 | MP0000534_abnormal_ureter_morphology | 0.49587601 |
139 | MP0003959_abnormal_lean_body | 0.49544515 |
140 | MP0001544_abnormal_cardiovascular_syste | 0.49296985 |
141 | MP0005385_cardiovascular_system_phenoty | 0.49296985 |
142 | MP0005023_abnormal_wound_healing | 0.48811291 |
143 | MP0002184_abnormal_innervation | 0.48781636 |
144 | MP0005391_vision/eye_phenotype | 0.48245836 |
145 | MP0004885_abnormal_endolymph | 0.48145101 |
146 | MP0005451_abnormal_body_composition | 0.46582825 |
147 | MP0009115_abnormal_fat_cell | 0.45385606 |
148 | MP0001485_abnormal_pinna_reflex | 0.45347193 |
149 | MP0000639_abnormal_adrenal_gland | 0.38675656 |
150 | MP0000569_abnormal_digit_pigmentation | 0.36206364 |
151 | MP0002135_abnormal_kidney_morphology | 0.35854452 |
152 | MP0002177_abnormal_outer_ear | 0.35060129 |
153 | MP0001614_abnormal_blood_vessel | 0.34875182 |
154 | MP0002092_abnormal_eye_morphology | 0.34749447 |
155 | MP0002128_abnormal_blood_circulation | 0.33940218 |
156 | MP0003942_abnormal_urinary_system | 0.32783628 |
157 | MP0000627_abnormal_mammary_gland | 0.32768332 |
158 | MP0006036_abnormal_mitochondrial_physio | 0.32060109 |
159 | MP0003828_pulmonary_edema | 0.31730418 |
160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31589721 |
161 | MP0005379_endocrine/exocrine_gland_phen | 0.31346324 |
162 | MP0005535_abnormal_body_temperature | 0.31317411 |
163 | MP0010329_abnormal_lipoprotein_level | 0.30924072 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glomerulonephritis (HP:0000099) | 9.39838405 |
2 | Aplasia involving bones of the extremities (HP:0009825) | 8.66337770 |
3 | Aplasia involving bones of the upper limbs (HP:0009823) | 8.66337770 |
4 | Aplasia of the phalanges of the hand (HP:0009802) | 8.66337770 |
5 | Partial duplication of thumb phalanx (HP:0009944) | 8.02041109 |
6 | Partial duplication of the phalanx of hand (HP:0009999) | 7.54613208 |
7 | Type 1 muscle fiber predominance (HP:0003803) | 7.40286961 |
8 | Nephritis (HP:0000123) | 6.74186994 |
9 | Alacrima (HP:0000522) | 6.44394005 |
10 | Increased connective tissue (HP:0009025) | 6.36683364 |
11 | Recurrent corneal erosions (HP:0000495) | 5.94884714 |
12 | Abnormality of incisor morphology (HP:0011063) | 5.92096590 |
13 | Exercise-induced myalgia (HP:0003738) | 5.84392262 |
14 | Muscle fiber splitting (HP:0003555) | 5.81042056 |
15 | Protrusio acetabuli (HP:0003179) | 5.67556401 |
16 | Muscle fiber inclusion bodies (HP:0100299) | 5.66221526 |
17 | Conical tooth (HP:0000698) | 5.65612480 |
18 | Decreased lacrimation (HP:0000633) | 5.43662294 |
19 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.33463415 |
20 | Round ear (HP:0100830) | 5.26902256 |
21 | Corneal erosion (HP:0200020) | 5.17551959 |
22 | Exercise-induced muscle cramps (HP:0003710) | 5.10922540 |
23 | Nemaline bodies (HP:0003798) | 4.92085284 |
24 | Nasolacrimal duct obstruction (HP:0000579) | 4.74925219 |
25 | Mixed hearing impairment (HP:0000410) | 4.74523336 |
26 | Flat cornea (HP:0007720) | 4.69924408 |
27 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 4.58122354 |
28 | Increased variability in muscle fiber diameter (HP:0003557) | 4.54632222 |
29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.39268687 |
30 | Xerostomia (HP:0000217) | 4.36463812 |
31 | Broad metatarsal (HP:0001783) | 4.32952826 |
32 | Slender build (HP:0001533) | 4.27678995 |
33 | Abnormality of the salivary glands (HP:0010286) | 4.24632100 |
34 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.22345668 |
35 | Ankle contracture (HP:0006466) | 4.20518181 |
36 | Corneal dystrophy (HP:0001131) | 4.15321789 |
37 | Duplication of thumb phalanx (HP:0009942) | 4.05267293 |
38 | Aplasia of the musculature (HP:0100854) | 4.02594026 |
39 | Distal arthrogryposis (HP:0005684) | 3.95837419 |
40 | Calf muscle hypertrophy (HP:0008981) | 3.88858167 |
41 | Abnormality of the lacrimal duct (HP:0011481) | 3.81474758 |
42 | Abnormality of permanent molar morphology (HP:0011071) | 3.72674114 |
43 | Abnormality of the dental root (HP:0006486) | 3.72674114 |
44 | Taurodontia (HP:0000679) | 3.72674114 |
45 | Spinal rigidity (HP:0003306) | 3.71610481 |
46 | Concave nail (HP:0001598) | 3.71207049 |
47 | Hyperkalemia (HP:0002153) | 3.70554878 |
48 | Ulnar deviation of the wrist (HP:0003049) | 3.69945562 |
49 | Difficulty running (HP:0009046) | 3.65989038 |
50 | Broad hallux (HP:0010055) | 3.64274014 |
51 | Polar cataract (HP:0010696) | 3.62866395 |
52 | Follicular hyperkeratosis (HP:0007502) | 3.59341199 |
53 | Abnormality of the nasolacrimal system (HP:0000614) | 3.55277629 |
54 | Abnormality of molar morphology (HP:0011070) | 3.54653917 |
55 | Abnormality of molar (HP:0011077) | 3.54653917 |
56 | Hyporeflexia of lower limbs (HP:0002600) | 3.53372960 |
57 | Myopathic facies (HP:0002058) | 3.49984982 |
58 | Abnormality of the dental pulp (HP:0006479) | 3.38229745 |
59 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.37105135 |
60 | Abnormality of the musculature of the hand (HP:0001421) | 3.35148109 |
61 | Premature rupture of membranes (HP:0001788) | 3.30864770 |
62 | Calcaneovalgus deformity (HP:0001848) | 3.27690190 |
63 | Muscle stiffness (HP:0003552) | 3.25373824 |
64 | Myotonia (HP:0002486) | 3.22394909 |
65 | EMG: myopathic abnormalities (HP:0003458) | 3.16871133 |
66 | Myoglobinuria (HP:0002913) | 3.16201099 |
67 | Deformed tarsal bones (HP:0008119) | 3.11383151 |
68 | Wrist flexion contracture (HP:0001239) | 3.04331036 |
69 | Broad toe (HP:0001837) | 3.01794434 |
70 | Soft skin (HP:0000977) | 2.97490244 |
71 | Abnormality of the calf musculature (HP:0001430) | 2.96791399 |
72 | Stage 5 chronic kidney disease (HP:0003774) | 2.94921453 |
73 | Striae distensae (HP:0001065) | 2.93385225 |
74 | Hypoplasia of the ulna (HP:0003022) | 2.82174180 |
75 | Absent phalangeal crease (HP:0006109) | 2.81914201 |
76 | Heterochromia iridis (HP:0001100) | 2.81762511 |
77 | Preaxial foot polydactyly (HP:0001841) | 2.73317638 |
78 | Complement deficiency (HP:0004431) | 2.71555073 |
79 | Achilles tendon contracture (HP:0001771) | 2.61389243 |
80 | Hematuria (HP:0000790) | 2.58546781 |
81 | Proximal amyotrophy (HP:0007126) | 2.58393863 |
82 | Bronchomalacia (HP:0002780) | 2.57638370 |
83 | Rectal prolapse (HP:0002035) | 2.56569931 |
84 | Abnormality of the antihelix (HP:0009738) | 2.55658932 |
85 | Mitral valve prolapse (HP:0001634) | 2.53224333 |
86 | Shallow orbits (HP:0000586) | 2.50510696 |
87 | Limb-girdle muscle weakness (HP:0003325) | 2.49138364 |
88 | Abnormality of the incisor (HP:0000676) | 2.46473443 |
89 | Absent radius (HP:0003974) | 2.41175635 |
90 | Cerebral aneurysm (HP:0004944) | 2.40626943 |
91 | Difficulty climbing stairs (HP:0003551) | 2.37147025 |
92 | Abnormality of the Achilles tendon (HP:0005109) | 2.36418467 |
93 | Cupped ear (HP:0000378) | 2.34761986 |
94 | Amyloidosis (HP:0011034) | 2.33025839 |
95 | Aortic dissection (HP:0002647) | 2.32332614 |
96 | Frequent falls (HP:0002359) | 2.31854640 |
97 | Abnormal finger flexion creases (HP:0006143) | 2.30417800 |
98 | Bladder diverticulum (HP:0000015) | 2.29884046 |
99 | Increased corneal curvature (HP:0100692) | 2.29512768 |
100 | Keratoconus (HP:0000563) | 2.29512768 |
101 | Overfolded helix (HP:0000396) | 2.29343710 |
102 | Hyponatremia (HP:0002902) | 2.29177348 |
103 | Neonatal short-limb short stature (HP:0008921) | 2.27197555 |
104 | Absent forearm bone (HP:0003953) | 2.25839683 |
105 | Aplasia involving forearm bones (HP:0009822) | 2.25839683 |
106 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.25241511 |
107 | Abnormality of the radial head (HP:0003995) | 2.23648663 |
108 | Exostoses (HP:0100777) | 2.21356353 |
109 | Ridged nail (HP:0001807) | 2.19800133 |
110 | Hyperextensible skin (HP:0000974) | 2.19028025 |
111 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18862713 |
112 | Abnormally folded helix (HP:0008544) | 2.18032933 |
113 | Cubitus valgus (HP:0002967) | 2.17188582 |
114 | Hypoplastic ischia (HP:0003175) | 2.16544837 |
115 | Bulbar palsy (HP:0001283) | 2.16224456 |
116 | Dilatation of the ascending aorta (HP:0005111) | 2.14851220 |
117 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 2.13556305 |
118 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.12017856 |
119 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.11813563 |
120 | Muscular dystrophy (HP:0003560) | 2.07944335 |
121 | Neck muscle weakness (HP:0000467) | 2.06289271 |
122 | Hypoplasia of the radius (HP:0002984) | 2.05398825 |
123 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.05257453 |
124 | Atrophic scars (HP:0001075) | 2.03724816 |
125 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.02981230 |
126 | Narrow nasal bridge (HP:0000446) | 2.02909305 |
127 | Abnormality of sodium homeostasis (HP:0010931) | 2.00647641 |
128 | Hypoventilation (HP:0002791) | 2.00075860 |
129 | Turricephaly (HP:0000262) | 1.98027104 |
130 | Sudden death (HP:0001699) | 1.97856151 |
131 | Tarsal synostosis (HP:0008368) | 1.93565516 |
132 | Vertebral compression fractures (HP:0002953) | 1.92970707 |
133 | Nephrotic syndrome (HP:0000100) | 1.91165491 |
134 | Abnormality of complement system (HP:0005339) | 1.89544522 |
135 | Distal lower limb muscle weakness (HP:0009053) | 1.89524618 |
136 | Bell-shaped thorax (HP:0001591) | 1.88835129 |
137 | Abnormality of the ischium (HP:0003174) | 1.88680104 |
138 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.88594101 |
139 | Subaortic stenosis (HP:0001682) | 1.88594101 |
140 | Generalized amyotrophy (HP:0003700) | 1.88500995 |
141 | Arterial tortuosity (HP:0005116) | 1.87796562 |
142 | Rhabdomyolysis (HP:0003201) | 1.86463058 |
143 | Cervical subluxation (HP:0003308) | 1.86354334 |
144 | Synostosis involving the elbow (HP:0003938) | 1.85449663 |
145 | Humeroradial synostosis (HP:0003041) | 1.85449663 |
146 | Fragile skin (HP:0001030) | 1.84609040 |
147 | Hypophosphatemia (HP:0002148) | 1.84480975 |
148 | Congenital glaucoma (HP:0001087) | 1.83955710 |
149 | Genu recurvatum (HP:0002816) | 1.83643055 |
150 | Hip contracture (HP:0003273) | 1.83037112 |
151 | Pulmonary artery stenosis (HP:0004415) | 1.82507606 |
152 | Malignant hyperthermia (HP:0002047) | 1.82315482 |
153 | Pterygium (HP:0001059) | 1.82279672 |
154 | Hyperactive renin-angiotensin system (HP:0000841) | 1.81707841 |
155 | Asymmetric septal hypertrophy (HP:0001670) | 1.81297487 |
156 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.80822648 |
157 | Joint laxity (HP:0001388) | 1.80494341 |
158 | Vascular tortuosity (HP:0004948) | 1.79908351 |
159 | Focal motor seizures (HP:0011153) | 1.77971321 |
160 | Hypoplasia of the iris (HP:0007676) | 1.77322550 |
161 | Shoulder girdle muscle weakness (HP:0003547) | 1.76244796 |
162 | Abnormality of the calcaneus (HP:0008364) | 1.76014943 |
163 | Biconcave vertebral bodies (HP:0004586) | 1.75723051 |
164 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.73528463 |
165 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.73528463 |
166 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.73391399 |
167 | Synostosis involving bones of the feet (HP:0009140) | 1.73391399 |
168 | Vascular calcification (HP:0004934) | 1.72853357 |
169 | Abnormality of primary teeth (HP:0006481) | 1.72594037 |
170 | Pelvic girdle muscle weakness (HP:0003749) | 1.72556631 |
171 | Hypoplasia of dental enamel (HP:0006297) | 1.71117071 |
172 | Anterior segment dysgenesis (HP:0007700) | 1.70487912 |
173 | Limited hip movement (HP:0008800) | 1.69667373 |
174 | Limited elbow extension (HP:0001377) | 1.68729626 |
175 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.67944170 |
176 | Nonprogressive disorder (HP:0003680) | 1.67938183 |
177 | Hypodontia (HP:0000668) | 1.67246558 |
178 | Distal lower limb amyotrophy (HP:0008944) | 1.66273167 |
179 | Microdontia (HP:0000691) | 1.65756743 |
180 | Aortic aneurysm (HP:0004942) | 1.64956489 |
181 | Cardiovascular calcification (HP:0011915) | 1.62568668 |
182 | Postural instability (HP:0002172) | 1.61152154 |
183 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.54258065 |
184 | Nephrocalcinosis (HP:0000121) | 1.53962052 |
185 | Renal tubular acidosis (HP:0001947) | 1.52119408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 4.96989405 |
2 | PHKG2 | 3.83189166 |
3 | PHKG1 | 3.83189166 |
4 | TTN | 3.79951817 |
5 | TRPM7 | 3.17206414 |
6 | GRK7 | 2.90454484 |
7 | CAMK2B | 2.87990540 |
8 | TRIB3 | 2.83428119 |
9 | DDR2 | 2.56651144 |
10 | RIPK1 | 2.53360690 |
11 | RIPK4 | 2.33098100 |
12 | NME1 | 2.09888013 |
13 | ARAF | 2.08440581 |
14 | MAP3K7 | 2.06468091 |
15 | DAPK2 | 2.05250064 |
16 | MAP3K9 | 1.92652856 |
17 | DMPK | 1.76748474 |
18 | PRKD3 | 1.75681331 |
19 | NTRK3 | 1.69375076 |
20 | PINK1 | 1.69210651 |
21 | MAPK15 | 1.69180414 |
22 | NLK | 1.62066915 |
23 | MAP2K4 | 1.55992675 |
24 | ERN1 | 1.54373236 |
25 | MAPK7 | 1.47604583 |
26 | PDGFRA | 1.47547116 |
27 | KSR2 | 1.45063873 |
28 | SIK1 | 1.43128321 |
29 | PIK3CG | 1.41487544 |
30 | MST1R | 1.40397727 |
31 | EPHA4 | 1.35658537 |
32 | PAK6 | 1.27229432 |
33 | MAP2K3 | 1.24322332 |
34 | TAOK1 | 1.20633077 |
35 | EPHB1 | 1.17423677 |
36 | MAP3K6 | 1.15796966 |
37 | MAP3K4 | 1.13138250 |
38 | MAPK12 | 1.12409542 |
39 | PRKCH | 1.12347491 |
40 | PIK3CA | 1.08527206 |
41 | PDK4 | 1.08269014 |
42 | PDK3 | 1.08269014 |
43 | AKT2 | 1.08262089 |
44 | LATS2 | 1.07817871 |
45 | MAPK4 | 1.04409057 |
46 | FER | 1.04020952 |
47 | GRK1 | 1.03819811 |
48 | STK38 | 1.02075943 |
49 | MAP3K3 | 0.98130554 |
50 | STK10 | 0.97256630 |
51 | PDK2 | 0.96013132 |
52 | MKNK1 | 0.95247033 |
53 | MUSK | 0.94668853 |
54 | NTRK2 | 0.94580494 |
55 | ADRBK1 | 0.92655517 |
56 | FGFR4 | 0.92139838 |
57 | NTRK1 | 0.89326541 |
58 | ICK | 0.88156138 |
59 | BMX | 0.87817522 |
60 | EPHA3 | 0.87563044 |
61 | PAK4 | 0.83682025 |
62 | LMTK2 | 0.82491787 |
63 | TBK1 | 0.81905933 |
64 | NEK1 | 0.81239361 |
65 | IRAK1 | 0.80503609 |
66 | PTK2B | 0.80014908 |
67 | MINK1 | 0.79549794 |
68 | EIF2AK2 | 0.79419813 |
69 | RET | 0.78540451 |
70 | CSK | 0.78368298 |
71 | MYLK | 0.77360145 |
72 | PAK3 | 0.77279550 |
73 | MAPKAPK3 | 0.77182873 |
74 | CAMKK1 | 0.76750518 |
75 | YES1 | 0.75784227 |
76 | LATS1 | 0.75371688 |
77 | FGFR2 | 0.74573185 |
78 | MAP3K2 | 0.72514005 |
79 | RPS6KL1 | 0.71744215 |
80 | RPS6KC1 | 0.71744215 |
81 | MAPKAPK5 | 0.71713925 |
82 | TGFBR2 | 0.71523057 |
83 | PRKD1 | 0.69768731 |
84 | FGFR1 | 0.68659029 |
85 | MAP3K1 | 0.68276432 |
86 | TSSK6 | 0.67825967 |
87 | SGK2 | 0.67700794 |
88 | CDK5 | 0.66924999 |
89 | TIE1 | 0.62683291 |
90 | NEK6 | 0.62027541 |
91 | JAK2 | 0.61974059 |
92 | RPS6KA6 | 0.59977358 |
93 | TESK1 | 0.58579767 |
94 | GRK5 | 0.58143164 |
95 | SGK3 | 0.57958866 |
96 | TYRO3 | 0.55286679 |
97 | PKN2 | 0.55283080 |
98 | PRKAA2 | 0.55155717 |
99 | PTK6 | 0.53654426 |
100 | FGFR3 | 0.53318915 |
101 | TNIK | 0.53132840 |
102 | MAP2K1 | 0.52361993 |
103 | CAMK1G | 0.51961873 |
104 | IRAK2 | 0.51661186 |
105 | MTOR | 0.51121979 |
106 | CAMK2G | 0.51098491 |
107 | PDGFRB | 0.50291641 |
108 | CAMK1 | 0.49206707 |
109 | PRKD2 | 0.48893030 |
110 | STK11 | 0.48583836 |
111 | KSR1 | 0.47840585 |
112 | SGK494 | 0.47426853 |
113 | SGK223 | 0.47426853 |
114 | SGK1 | 0.47294085 |
115 | RAF1 | 0.47288512 |
116 | MARK2 | 0.46890097 |
117 | PDPK1 | 0.46086270 |
118 | IKBKE | 0.45357917 |
119 | ROCK1 | 0.44827986 |
120 | PRKAA1 | 0.44827110 |
121 | MAP3K13 | 0.44804878 |
122 | JAK1 | 0.44795577 |
123 | TYK2 | 0.44462832 |
124 | PAK2 | 0.43934637 |
125 | FLT3 | 0.43137249 |
126 | MAP2K6 | 0.42677602 |
127 | GSK3A | 0.42244589 |
128 | PKN1 | 0.41448355 |
129 | PDK1 | 0.40234786 |
130 | MAP2K2 | 0.40052782 |
131 | ERBB4 | 0.39244682 |
132 | RPS6KA3 | 0.39079941 |
133 | MOS | 0.38936440 |
134 | STK38L | 0.38762946 |
135 | MET | 0.38615869 |
136 | UHMK1 | 0.37689541 |
137 | INSR | 0.35437728 |
138 | MAPK3 | 0.34631184 |
139 | PRKACA | 0.33814299 |
140 | ABL2 | 0.29969125 |
141 | EEF2K | 0.28781076 |
142 | MAP3K14 | 0.28247534 |
143 | ROCK2 | 0.27918422 |
144 | BRAF | 0.26937442 |
145 | HIPK2 | 0.25021572 |
146 | PRKACG | 0.22253211 |
147 | NEK9 | 0.21122404 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.68260967 |
2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.95017710 |
3 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.37117335 |
4 | Melanoma_Homo sapiens_hsa05218 | 2.25535625 |
5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.15446176 |
6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.08720727 |
7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.06849138 |
8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.99681791 |
9 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.86404825 |
10 | Focal adhesion_Homo sapiens_hsa04510 | 1.79210856 |
11 | Malaria_Homo sapiens_hsa05144 | 1.71778715 |
12 | Prion diseases_Homo sapiens_hsa05020 | 1.70104784 |
13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67043300 |
14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66352081 |
15 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64891785 |
16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63710145 |
17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60319472 |
18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.57652980 |
19 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49460977 |
20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.44228002 |
21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.42881616 |
22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42710818 |
23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41251605 |
24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.37432081 |
25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36715529 |
26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34069124 |
27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30860930 |
28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.29130196 |
29 | Salivary secretion_Homo sapiens_hsa04970 | 1.27047998 |
30 | Lysine degradation_Homo sapiens_hsa00310 | 1.26508643 |
31 | GABAergic synapse_Homo sapiens_hsa04727 | 1.25779751 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.25669395 |
33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20981258 |
34 | Insulin resistance_Homo sapiens_hsa04931 | 1.19430960 |
35 | Renin secretion_Homo sapiens_hsa04924 | 1.17612243 |
36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17016308 |
37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16501967 |
38 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.16215517 |
39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15936335 |
40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.15661621 |
41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15586073 |
42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15444602 |
43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15420085 |
44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15392759 |
45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14520177 |
46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13908767 |
47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.13596060 |
48 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13560979 |
49 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12272820 |
50 | Pathways in cancer_Homo sapiens_hsa05200 | 1.11641124 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09667229 |
52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08193532 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 1.07925025 |
54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07360797 |
55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06417152 |
56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04200095 |
57 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02348298 |
58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01870641 |
59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01009541 |
60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00446956 |
61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99716638 |
62 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98796766 |
63 | Melanogenesis_Homo sapiens_hsa04916 | 0.95711505 |
64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95140695 |
65 | Glioma_Homo sapiens_hsa05214 | 0.94697589 |
66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94691909 |
67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92359841 |
68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91166072 |
69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.89248821 |
70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.85352517 |
71 | Long-term depression_Homo sapiens_hsa04730 | 0.85082827 |
72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84412343 |
73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.84109281 |
74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.83426448 |
75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81742059 |
76 | Morphine addiction_Homo sapiens_hsa05032 | 0.81646702 |
77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81046602 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80066913 |
79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79392347 |
80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78608004 |
81 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.78589630 |
82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78389810 |
83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.77355588 |
84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76987442 |
85 | Bile secretion_Homo sapiens_hsa04976 | 0.76540446 |
86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.76391251 |
87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76067273 |
88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.74959181 |
89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74339691 |
90 | Gap junction_Homo sapiens_hsa04540 | 0.72283155 |
91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68682659 |
92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67994646 |
93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64890010 |
94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64540495 |
95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64365617 |
96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63792088 |
97 | Tight junction_Homo sapiens_hsa04530 | 0.62733722 |
98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62664957 |
99 | Platelet activation_Homo sapiens_hsa04611 | 0.62233727 |
100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61783895 |
101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60477326 |
102 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59961447 |
103 | Axon guidance_Homo sapiens_hsa04360 | 0.59173251 |
104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58197852 |
105 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56152524 |
106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55786280 |
107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55175031 |
108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53562061 |
109 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53541542 |
110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53429535 |
111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53199417 |
112 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52847940 |
113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.52002474 |
114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51932450 |
115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51566310 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50748244 |
117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49925967 |
118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48944778 |
119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48207348 |
120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48155149 |
121 | Bladder cancer_Homo sapiens_hsa05219 | 0.47513009 |
122 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46557399 |
123 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45868643 |
124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45041287 |
125 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44775570 |
126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44645724 |
127 | Adherens junction_Homo sapiens_hsa04520 | 0.44626631 |
128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43836306 |
129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43781785 |
130 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43534029 |
131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43189619 |
132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42680782 |
133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42552113 |
134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42130193 |
135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41864035 |
136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39213258 |
137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38392948 |
138 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37727714 |
139 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35547214 |
140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33552561 |
141 | ABC transporters_Homo sapiens_hsa02010 | 0.31995442 |
142 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.22286297 |
143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18091358 |
144 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.17698233 |
145 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.16223583 |